Professor Sun y Myint

F.R.C.P (Edin); F.R.C.R (London); F.F.R.C.S.I (Dublin); F.R.C.R; F.I.C.S (Chicago); F.R.S.M

Specialises in

I introduced contact radiotherapy (Papillon) for rectal cancer into the UK in 1993. This treatment is mainly indicated for elderly patients with early low rectal cancers for which surgery is the standard treatment. However, patients with medical co morbidities or advanced age have higher surgical risk and contact radiotherapy can be considered as an alternative treatment. Salvage surgery can be considered for small number who did not respond to contact radiotherapy. Patient can then accept the surgical risk without compromising their chance of cure.

Get in touch

Important information about Covid-19 tests

COVID-19 testing or antibody tests are not available as a standalone service at Spire Murrayfield Hospital Wirral.


Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Submit my enquiry

Additional information

. Consultant Oncologist, Wirral Hospitals NHS Trust. Lead Clinician (Clatterbridge Papillon Centre).

Prof. Sun Myint graduated from IM (2) Mingaladon, Burma in 1972. He was appointed as a Clinical scientist for MRC Neutron trial project in 1983 and chaired the colorectal sub-group for neutron trials until 1995. He is now the Lead Clinician in GI malignancies at Clatterbridge Centre for Oncology where he worked as a consultant for over 25 years. His main research interest is in the treatment of rectal cancers. He introduced contact radiotherapy (Papillon) into the UK and started treating patients at Clatterbridge from 1993. So far, he has treated over 700 patients using Papillon technique which is the world largest cohort of patients. He helped design a new contact radiotherapy machine together with his mentor Prof Jean Pierre Gerard in collaboration with Ariane Company. He is the director of minimally invasive radiotherapy course at Clatterbridge.. . He was appointed specialist advisor for NICE for rectal brachytherapy and helped write the guide lines published in Dec 2006. He was a member of NCRI rectal and anal sub group committees (1995-2012) and now serves as an advisor to the NCRI rectal sub group. He has published over 50 peer reviewed publications and an author of 4 text book chapters. He was the guest editor for special issue of Clinical Oncology (Vol. 19: No 9; Nov, 2007) on radiotherapy for early rectal cancer.. . He served as the oncology representative on the Council of Association of Coloproctology from 2006-2009. He was elected on the Council of the Royal College of Radiologist (2009-2012). In 2008 he was awarded Cochrane Shanks/Jalil travelling professor by the Royal College of Radiologist. In May 2011, he was appointed by GEC-ESTRO committee to chair the brachytherapy group for rectal and anal cancers.. . He was elected as the President of International Contact Radiotherapy Society (ICONE) in May 2013. He is the clinician in charge of Papillon Unit at the Clatterbridge Cancer Centre which has opened in June 2013. In recognition of his contributions to medicine and oncology he was awarded an Honorary Professor by the University of Liverpool in 2012.